Literature DB >> 26275210

Establishment of a bioluminescence model for microenvironmentally induced oral carcinogenesis with implications for screening bioengineered scaffolds.

Salwa Suliman1,2,3, Himalaya Parajuli2,3, Yang Sun4, Anne Christine Johannessen2,5,6, Anna Finne-Wistrand4, Emmet McCormack7,8, Kamal Mustafa1, Daniela Elena Costea2,5,6.   

Abstract

BACKGROUND: Microenvironmental cues play a major role in head and neck cancer. Biodegradable scaffolds used for bone regeneration might also act as stimulative cues for head and neck cancer. The purpose of this study was to establish an experimental model for precise and noninvasive evaluation of tumorigenic potential of microenvironmental cues in head and neck cancer.
METHODS: Bioluminescence was chosen to image tumor formation. Early neoplastic oral keratinocyte (DOK) cells were luciferase-transduced (DOK(Luc) ), then tested in nonobese diabetic severe combined immunodeficient IL2rγnull mice either orthotopically (tongue) or subcutaneously for their potential as "screening sensors" for diverse microenvironmental cues.
RESULTS: Tumors formed after inoculation of DOK(Luc) were monitored easier by bioluminescence, and bioluminescence was more sensitive in detecting differences between various microenvironmental cues when compared to manual measurements. Development of tumors from DOK(Luc) grown on scaffolds was also successfully monitored noninvasively by bioluminescence.
CONCLUSION: The model presented here is a noninvasive and sensitive model for monitoring the impact of various microenvironmental cues on head and neck cancer in vivo.
© 2015 The Authors Head & Neck Published by Wiley Periodicals, Inc. Head Neck 38: E1177-E1187, 2016. © 2015 The Authors Head & Neck Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  bioluminescence; cancer; microenvironment; scaffold; tissue engineering

Mesh:

Substances:

Year:  2015        PMID: 26275210      PMCID: PMC5042037          DOI: 10.1002/hed.24187

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


INTRODUCTION

Recent evidence implicates environmental cues as key factors in cancer progression.1 Among the important determinants is the surrounding stroma, including fibroblasts, endothelial cells, infiltrating immune cells, and extracellular matrix components.2, 3 The scaffolds used in tissue engineering as provisional matrices for cell proliferation and extracellular matrix deposition can also act as microenvironmental cues. The surrounding tissues might react toward these by foreign body reactions or even tumor formation,4 and long‐term subcutaneous implants of nonabsorbable or slowly degrading materials were shown to be tumorigenic.5, 6 Thus, there is a great concern that certain biomaterials may be potential initiators of malignancies, and the size and surface roughness of certain biomaterials were already suggested to influence tumor formation.7 To date, at the regulatory level, the basic approach for biomaterials' safety is defined in the International Organization for Standardization 10993.8, 9 These tests start with an initial safety evaluation targeting leachable for cytotoxicity. Genotoxicity and evaluation of mRNA levels of proto‐oncogenes and tumor suppressor genes10 from mammalian or bacterial cells exposed to the biomaterials has also been used as methods for safety check.11 Current carcinogenicity tests determine the tumorigenic potential of materials and/or their extracts from either single or multiple exposures or contacts over a period of the major portion of the life span of the test animal or transgenic mice.12 Long‐term, conventional 2‐year rodent bioassays are often not feasible, with questionable relevance also because of limitations associated with species extrapolation.13, 14 Finding a relevant animal model for every kind of human cancer is impractical, but preclinical animal xenograft tumor models, particularly heterotopic (subcutaneous), have proven useful especially in identifying cytotoxic agents.15, 16, 17, 18 On the other hand, although more technically demanding, the orthotopic xenograft models simulate the same local microenvironment and thus offer the advantage of less complicated translation to the clinical setting.19 Scaffolds used for bone regeneration in the oral and maxillofacial area might come in contact with the oral epithelium. Because over 90% of head and neck cancers are, as most of the human malignancies, of epithelial origin,20, 21 there is a need to study the potentially carcinogenic effect of degradable bioengineered scaffolds on oral epithelial cells. To study oral and head and neck carcinogenesis, both orthotopic and heterotopic (subcutaneous) models were previously developed by use of malignant cells derived from established oral or head and neck cancer.22 In this study, we chose to develop a xenotransplantation model by use of an early neoplastic oral keratinocyte (DOK) cell line derived from early neoplastic oral mucosa.23 These cells were found to be partly transformed but nontumorigenic in nude mice, and were described as having potential as “screening recipients” for carcinogens in vitro.23 Different in vivo optical imaging modalities have been tested in various tumor models.24, 25, 26 However, there is a need for a noninvasive head and neck cancer model with the ability to detect possible tumorigenic effects of various microenvironmental cues, including implanted scaffolds. Bioluminescent imaging is a well‐established method in preclinical investigation of the complexity of cancers27, 28, 29 including head and neck cancer,30, 31 but for a screening of the potential to fully transform and generate malignant tumors from the early neoplastic cells, the application of bioluminescence would offer a novel noninvasive approach. In carcinogenicity testing of biomaterials, controls of a comparable form and shape should be included. However, in the presented system, the use of appropriate controls is not necessary because the inclusion of a positive environment with the use of carcinoma‐associated fibroblasts (CAFs) has been developed. The noninvasive in vivo visualization for several weeks also provides additional unique advantages over the aforementioned established carcinogenicity testing systems. To achieve real‐time bioluminescence in this study, DOK cells were first transduced to contain the firefly luciferase. They were then tested in vivo in NSG mice for their potential as “screening sensors” for diverse microenvironmental cues, such as various types of head and neck CAFs and copolymer scaffolds intended for tissue engineering. The biodegradable poly l‐lactide‐co‐ɛ‐caprolactone (poly[LLA‐co‐CL]), an aliphatic polyester copolymer of l‐lactic acid and ɛ‐caprolactone, has been extensively studied at our laboratory as a scaffold for bone regeneration proving its biocompatibility and osteo‐conductivity,8, 32 and, hence, was chosen for developing this model.

MATERIALS AND METHODS

Cell choice and maintenance

The DOK cell line was purchased from The European Collection of Cell Cultures (Salisbury, Wiltshire, UK).23 They were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS; Invitrogen, Waltham, MA), 20 μg/mL L‐glutamine, 5 μg/mL hydrocortisone (all from Sigma, St. Louis, MO). CAFs (n = 3; CAF1, CAF15_13, and CAF15_23) were isolated from histologically confirmed head and neck squamous cell carcinoma, after receiving informed consent. They were maintained in FAD medium: DMEM/Ham's F12 1:3 mixture, 1% L‐glutamine, 0.4 μg/mL hydrocortisone, 50 μg/mL ascorbic acid, 10 ng/mL epidermal growth factor, 5 μg/mL insulin, and 20 μg/mL transferrin and linoleic acid (all from Sigma) with 10% FCS.

Luciferase transduction of early neoplastic oral keratinocytes

Virus production

DOK wild type (DOKWT) cells were transduced with a tTA, L192 construct (expressing luciferase).33 Infectious retroviral vector particles were produced in Phoenix A cells (LGC Standards AB, Boras, Sweden) cultured in DMEM, supplemented with 10% FCS, 1% penicillinstreptomycin, and 1% glutamine. When 70% to 80% was confluent, 8 μL of 50 mM chloroquine (Sigma) was added. Four micrograms of DNA construct (tTA, L192) was mixed with 128 μL of 2M calcium chloride (CaCl2) and sterile ddH2O to a total volume of 1 mL plus 1 mL of 2×HEPES‐buffered (Sigma) and transferred onto each plate. After 12‐hour incubation, the medium was replaced by a fresh medium and by DOK's medium after 24 hours.

Infection and selection of luciferase‐transduced early neoplastic oral keratinocyte

The virus supernatant was collected, filtered, and gene transfer enhanced with protamine sulfate (5 μg/mL). DOKWT were seeded at 3 different seeding densities (25 × 103; 50 × 103; and 100 × 103 cells/well) in a 6‐well plate and centrifuged at 1200 g for 90 minutes. The virus supernatant was replaced with the DOK medium 24 hours postinfection. Successfully infected DOK cells were selected by puromycin (1 μg/mL; Sigma). To obtain a cell‐clone with a stable, high expression of luciferase, transduced DOK cells were sorted using fluorescence‐activated cell sorter (FACS Aria SORP, BD Biosciences, San Jose, CA).

Selection of highly bioluminescent early neoplastic oral keratinocyte luciferase‐transduced cells

Approximately 1 × 106 cells of each group in 100 μL DOK medium were transferred to 96‐well plate with 1 well containing 100 μL of DOK medium only for background autofluorescence. Luciferin, (1.6 g/L of D‐luciferin; Biosynth AG, Staad, Switzerland) was added 10 minutes before imaging in the Time‐Domain Small Molecular Imager Optix MX3 (ART; GE Healthcare, Little Chalfont, UK). Using the OptiView acquisition software (ART Advanced Research Technologies, Quebec, Canada), the region of interest was chosen and plates were scanned with the scan step 1.0 mm and integration time 0.1 seconds.

Assessment of cell morphology and proliferation

Both cell types, DOKWT and early neoplastic oral keratinocyte luciferase‐transduced (DOKLuc), were cultured at passages (45–48) and their morphology was compared under a light microscope (Nikon TS100; Nikon, Tokyo, Japan). The growth rate was analyzed using a colorimetric assay based on methylthiazol tetrazolium (Sigma) and measured at 570 nm using a microplate reader (BMG LABTECH, GmbH, Ortenberg, Germany).

Assessment of tumorigenicity in vivo

Both DOKWT and DOKLuc cells were cultured and allowed to reach their log phase before they were trypsinized and suspended in 50 μL of growth factor‐reduced matrigel (BD Biosciences). The cells were inoculated at 2 different densities, low (1 × 103) and high (1 × 105), at 2 different locations, the tongue and subcutaneously in the back of 8 to 10 weeks old male nonobese diabetic severe combined immunodeficient IL2rγ mice (NSG) (University of Bergen ‐ originally a generous gift from Prof. Leonard D. Shultz, Jackson Laboratories, Bar Harbor, ME; n = 24, 6 mice for each group). Weekly for 6 weeks, tumor volumes for both cell types were manually assessed by digital caliper, using the formula [length × (width2)/2]. In the group inoculated with DOKLuc, tumor development was also measured weekly by bioluminescence. We euthanized the mice after 45 days and harvested tissues for histology.

Orthotopic tongue xenograft mouse model for early neoplastic oral keratinocyte + carcinoma‐associated fibroblast co‐inoculations

To create a positive tumor formation control, 1 × 103 DOKWT were suspended with 1 × 105 CAFs (CAF1) in 50 μL matrigel and inoculated in the tongue of NSG mice (n = 12; 6 mice for each group). Tumors were measured manually up to 45 days. To assess the sensitivity of bioluminescence to differentiate between tumors formed by different strains of CAFs, DOKLuc in a density of 1 × 103 were co‐inoculated in combination with 1 × 105 of 2 different strains of CAFs (CAF15_13 and CAF15_23) in the tongue. The total number of animals was 24 with at least 6 for each group. The development of the tumors in this group was followed up manually and evaluated weekly by bioluminescence.

Preparation of cell‐seeded poly l‐lactide‐co‐ɛ‐caprolactone scaffolds for ectopic subcutaneous scaffold xenograft

The copolymer poly(LLA‐co‐CL) was polymerized from ɛ‐caprolactone (Sigma–Aldrich, Germany) and LLA (Boehringer, Ingelheim, Germany) by ring‐open‐polymerization, as previously described.32 The average molecular weight of the purified copolymer was 100,000 and polydispersity index 1.3 determined by Size Exclusion Chromatography (Polymer Laboratories, Shropshire, UK). The copolymer was composed of 75 mol % LLA and 25 mol % caprolactone, confirmed by 1H‐NMR (Bruker Avance 400, Billerica, MA). The porous scaffolds were prepared by solvent casting particulate leaching32 and a disc‐shaped scaffold (diameter approximately 6 mm, thickness approximately 1.3 mm) was formed with >83% porosities. Porosities were calculated by a Micro‐CT (Sky Scan 1172 scanner, Kontich, Belgium) using 40 kV and 2.4 micron voxel and 3D analysis was carried using the software CT‐Analyzer version 1.13 (Bruker). The scaffolds were pre‐wet with DOK medium and left for 2 to 3 hours before being then seeded with cells, DOKLuc alone or DOKLuc + CAFs (CAF1). Three different densities of DOK were used (1 × 103, 1 × 105, and 1 × 106); the density of CAFs was fixed to 1 × 105. Plates were vortexed (Eppendorf, Hamburg, Germany) and the cells were allowed to attach overnight before scaffolds were xenotransplanted in 8 to 10‐week‐old NSG mice. The mice were anesthetized with Isoflurane (Isoba VetTM; Schering Plough, Kenilworth, NJ) before 2 incisions (1 cm) were made on their back. One incision was made between the upper limbs and another between the lower limbs, providing sufficient space for implantation of scaffolds and to avoid bioluminescence bleeding. Two scaffolds were implanted into each mouse, 1 scaffold with DOKLuc alone and the other with DOKLuc + CAFs. The different densities were distributed among all mice (n = 6). Wounds were closed with Histoacryl tissue adhesive (B. Braun Surgical AS, Melsungen, Germany). At 12 weeks, the animals were euthanized with CO2 overdose and scaffolds processed for histology.

Optical bioluminescence imaging

Mice were depilated and scanned after intraperitoneal delivery of 150 mg/kg of D‐luciferin. Animals were maintained under 1% gas anesthesia during scanning. Images were captured using In Vivo MS FX PRO (Carestream Health, Rochester, NY) and analyzed using Carestream MI SE version 5.0.6.20, 1 exposure of 90‐second duration.

Histology and immunohistochemistry

Samples were fixed in 4% paraformaldehyde before embedding in paraffin. Sections of 3 to 4 μm were stained with hematoxylineosin (Sigma). For p53 immunostaining, paraffin sections were deparaffinized and rehydrated. Epitope retrieval was performed by heating the sections in citrate buffer pH 6.0 in a microwave. Endogenous enzyme activity and unspecific binding were blocked using peroxidase block (DAKO, Golstrup, Denmark) and 10% normal goat serum (DAKO) for 5 minutes and 30 minutes, respectively, at room temperature. As primary antibody, p53 with a monoclonal specific antibody (DO‐7 clone, DAKO) 1:50 was incubated for 1 hour at room temperature. For negative controls, samples were treated with antibody diluents alone. The bound reaction was visualized using 3, 3′‐diaminobenzidine tetra hydrochloride (DAB, DAKO). Double staining with vimentin (DAKO) 1:1000 was carried out using a double stain kit (Envision G|2 double stain system; DAKO), in accord with the manufacturer's instructions. Tumor areas were calculated from areas of interest in hematoxylineosin sections using Olympus DP Soft 5.0 software (Munster, Germany).

Ethics statement

The ethical approval for patients with head and neck squamous cell carcinoma samples was obtained from the Regional Committees for Medical and Health Research Ethics (REK NO. 2010/48) and lesions were collected following ethical approval and written informed consent of the patients. All animal experiments were approved by the Norwegian Animal Research Authority and conducted in strict accordance with the European Convention for the Protection of Vertebrates used for Scientific Purposes (FOTS no. 20134643/20123961). All procedures were performed under isoflurane gas anesthesia, and all efforts were made to minimize suffering.

Statistical analysis

Average values were analyzed by IBM SPSS Statistics 21.0 (SPSS, Chicago, IL) and the data expressed as mean ± SEM. Paired t test or the independent Mann–Whitney U tests were used to compare differences between the tumors formed. Spearman's correlation was used to correlate the manual tumor measurements and histological measurements with corresponding bioluminescence signals. Differences were considered statistically significant when p < .05.

RESULTS

Successful transduction of early neoplastic oral keratinocyte with luciferase containing vector generated a new cell line

The bioluminescence signal recorded for DOKLuc cells cultured in vitro for 2 to 3 weeks posttransduction showed that the seeding density of 50 × 103 displayed the highest photons/mm2/sec (Figure 1A, white arrow). Cells derived following this protocol were expanded and used for further in vivo experiments. Light microscopy showed that DOKWT and DOKLuc had typical epithelial morphology and similar patterns of growth in the form of coherent islands. No signs of epithelial‐to‐mesenchymal transition could be observed in either (Figure 1B). The growth curve was comparable for the 2 cell types (p = .262), indicating that transduction with luciferase did not alter the in vitro growth potential of these cells (Figure 1C).
Figure 1

(A) Bioluminescence of early neoplastic oral keratinocyte luciferase‐transduced (DOK

(A) Bioluminescence of early neoplastic oral keratinocyte luciferase‐transduced (DOK The in vivo tumorigenic potential of DOK cells before and after transduction with luciferase expressing gene was evaluated after DOKWT and DOKLuc were inoculated in the tongue and also subcutaneously in NSG mice at low (1 × 103) and high (1 × 105) density. At the high inoculation density, visible tumors were detected with the same incidence after 2 weeks, at both sites, for both DOKWT and DOKLuc. At the low density, tumors formed only in the tongue, and after 4 weeks, with the same incidence for DOKWT and DOKLuc. There was no statistical significance between the volume of the tumors formed in both tongue and subcutaneously by DOKWT and DOKLuc at all timepoints (Figures 2A and 2B). The histological area of the tumors derived from DOKWT and DOKLuc at low density in the tongue (Figure 2C) and at high density subcutaneously (Figure 2D) did not show any statistical significant difference. The only statistical significant difference was found for the tongue tumors formed at higher inoculation density by DOKLuc than tumors formed by DOKWT (p < .05; Figure 2C). Tumor xenografts generated from DOKWT (Figures 2E–2G) showed the same histological picture as DOKLuc xenografts (Figures 2H–2J), with epithelial islands of atypical epithelial cells in the host stroma and keratin pearls.
Figure 2

Graphs comparing the growth rate (tumor volume) and the total area of tumors formed by either early neoplastic oral keratinocyte wild type (DOK

Graphs comparing the growth rate (tumor volume) and the total area of tumors formed by either early neoplastic oral keratinocyte wild type (DOK

Development of tumors formed after inoculation of early neoplastic oral keratinocyte luciferase transduced cells was easily monitored by bioluminescence

Luciferase activity increased with time after both tongue and subcutaneous inoculations for both inoculation densities (Figures 3A and 3B). The bioluminescence signal was significantly higher for the inoculations of DOKLuc at higher inoculation density at both tongue and subcutaneous locations (Figures 3C and 3D), at all timepoints, correlating well with the tumor growth curve as assessed by the manual measurements.
Figure 3

Bioluminescence (BLI) of mice for 5 weeks after inoculation with early neoplastic oral keratinocyte luciferase‐transduced (DOK

Bioluminescence (BLI) of mice for 5 weeks after inoculation with early neoplastic oral keratinocyte luciferase‐transduced (DOK

Both early neoplastic oral keratinocyte wild type and early neoplastic oral keratinocyte luciferase‐transduced were responsive to carcinoma‐associated fibroblast‐derived microenvironmental cues and bioluminescence was more sensitive than manual measurement in detecting differences between various types of microenvironmental cues

Co‐inoculating DOKWT with 105 CAFs in the tongues of NSG mice increased tumor incidence from 16.66% to 57.14% (Figure 4A). Histological sections of the tumors formed by DOKWT + CAF showed typical squamous cell carcinoma histology with invasive epithelial islands growing in the host stroma and keratin pearl formation (Figures 4D and 4E). The only 1 tumor formed by the DOKWT alone, which was detected manually, was found histologically to be surviving DOKWT cells within remnants of undissolved matrigel (Figures 4B and 4C). When 2 different types of fibroblasts (CAF15_13 and CAF15_23) were tested for their stimulative support for the in vivo growth of DOKLuc, bioluminescence seemed to be more sensitive than the manual measurement in detecting differences in the tumor growth of xenografts (Figures 4F and 4G), although the difference was not statistically significant. This difference was also observed by histological area calculations after 7 weeks, this time with statistical significance (p = .028; Figure 4H).
Figure 4

(A) Carcinoma‐associated fibroblasts (CAFs) increased tumor incidence of early neoplastic oral keratinocytes wild type (DOK)

(A) Carcinoma‐associated fibroblasts (CAFs) increased tumor incidence of early neoplastic oral keratinocytes wild type (DOK)

Both bioluminescence and manual measurement showed high correlation with histological area of the tumors, but tumor formation was detected earlier by bioluminescence

Bioluminescence consistently disclosed a higher number of tumors throughout all 5 weeks of monitoring compared to visible tumors measured manually by calipers (Figures 5A–5D). Both the tumor volume as quantified by caliper (manual) measurements and the bioluminescence signal from the corresponding tumor at the last timepoint showed a positive correlation with the tumor area quantified from histological sections (considered to be the “golden standard”). A stronger significant correlation (r = 0.846; p < .001) was found between the histological tumor area and bioluminescence signals than between the histological tumor area and the manual measurement (r = 0.739; p < .001; Figures 5E and 5F).
Figure 5

(A and B) Comparison of number of tumors detected by bioluminescence (BLI) and manually in the tongue inoculations at both densities. (C and D) Comparison in the skin inoculations (.

(A and B) Comparison of number of tumors detected by bioluminescence (BLI) and manually in the tongue inoculations at both densities. (C and D) Comparison in the skin inoculations (.

Development of tumors from early neoplastic oral keratinocyte luciferase‐transduced grown on poly l‐lactide‐co‐ɛ‐caprolactone scaffolds under different microenvironmental cues was successfully monitored noninvasively by bioluminescence

DOKLuc were cultured on poly(LLA‐co‐CL) scaffolds at 3 different densities with or without CAFs. Total photon count from bioluminescence showed significantly higher bioluminescence intensity of scaffolds xenotransplanted with DOKLuc + CAFs than of DOKLuc alone at all densities, just above the threshold 1 week after xenotransplantation and throughout the 12 weeks of in vivo imaging (106: p < .001; 105: p < .001; 103: p = .017; Figure 6C). In the scaffolds xenotransplanted with DOKLuc alone, no tumors were formed outside the scaffolds and the bioluminescence signal stayed within the same range throughout the 12 weeks of imaging (Figure 6A). In contrast, the bioluminescence intensity of scaffolds cocultured with CAFs increased with time (Figure 6B), indicating an increase in tumor growth over time, and this was confirmed by histology. After 12 weeks, histological analysis of xenotransplants of scaffolds with DOKLuc cells alone showed the presence of few atypical epithelial cells, limited to the scaffold area (Figures 7A, 7B, 7F, and 7G). Around the remnants of the scaffolds, scattered giant cells of mouse origin were observed (Figure 7K, blue arrow). The origin of the epithelial cells was confirmed by immunostaining using an antibody against human p53, recognizing only p53 mutated human cells, DOK. In contrast, the histology of xenografts of DOKLuc + CAFs scaffolds showed squamous epithelial tumor nests (confirmed by p53 positive staining; Figures 7C, 7D, 7I, and 7J), with many of the islands retaining differentiation and containing keratin pearls, growing within and outside the scaffold area, invading the surrounding connective tissue and musculature, thus displaying the characteristic hallmarks of head and neck carcinoma. Few fibroblasts were observed in the xenotransplants even after 12 weeks of growth in vivo in mice (Figure 7K, black arrow). Figure 7E shows the pronounced macroscopic differences observed during harvesting of the scaffolds.
Figure 6

(A) Bioluminescence images of a representative mouse carrying a scaffold with a low density (1 × 10

Figure 7

(A–D) Hematoxylin‐eosin staining showing histology of early neoplastic oral keratinocyte luciferase‐transduced (DOK

(A) Bioluminescence images of a representative mouse carrying a scaffold with a low density (1 × 10 (A–D) Hematoxylineosin staining showing histology of early neoplastic oral keratinocyte luciferase‐transduced (DOK

DISCUSSION

This study describes the development of a noninvasive, in vivo model for testing the tumorigenic potential of various microenvironmental cues, including scaffolds intended for use in tissue engineering. Numerous studies34 support the concept that carcinogenesis, including head and neck cancer, is a multistep process involving a premalignant phase of long‐term accumulated chromosomal alterations.35 The use of normal cells in tumor models is time‐consuming, if not irrelevant, because it is well‐known that the transformation of human cells is a long process, involving at least 5 to 7 mutagenic events, which are difficult to achieve in an experimental setting.20, 36 For the present model, the DOK cell line, exhibiting early neoplastic epithelial dysplastic features was selected as a “screening sensor.”23 To facilitate the noninvasive visualization of these cells after xenotransplantation, they were transduced with luciferase gene, successfully generating a new cell line, DOKLuc. The in vitro growth and behavioral characteristics of the transfected cells were comparable to those of the parent cells. To evaluate their behavior in vivo, both cell lines (DOKWT and DOKLuc) were xenotransplanted alone at low and high densities, both orthotopically, in the tongue, and ectopically, on the back of NSG mice. With a single exception for the tumor size when injected in the tongue at high density, DOKWT and DOKLuc showed a comparable in vivo behavior as well. This indicates that the DOK cell line retained a high degree of stability after transfection, although it carried a complex karyotype and multiple mutations, including p53 mutations. In accordance with previous oral carcinogenesis animal studies, the incidence and size of subcutaneous tumors in the present study was lower than those of tongue tumors.16 This could be related to a greater stimulation of lymphangiogenesis in the tongue area16 or simply because of the fact that orthotopic models allow cells to grow better in their original environment. When DOKWT cells were co‐inoculated with CAFs in the tongue, the incidence of tumor formation increased by more than 40% compared with tumors formed by DOKWT alone. This further highlights the important role of the microenvironmental cues in tumor initiation and early growth, supporting previous studies.37, 38 The tumor detected by manual measurements formed by DOKWT was proven later on, histologically, to contain mainly remnants of matrigel, which might have given the mass that could be measurable by the caliper, and only few islands of nonproliferative DOK cells. This illustrates one of the drawbacks of the manual measurements that can be avoided by the use of other methods, such as bioluminescence. In this study, bioluminescence detected more than 50% of the total number of tumors formed in the tongue by DOKLuc from the first week; much earlier than tumor detection with caliper measurements. In the skin tumors, 6 of 7 were visible by bioluminescence from the first week. One of the tumors was from low density inoculations, which were too small for detection by manual measurements, but it was later confirmed histologically. The total number of tumors detected by bioluminescence was significantly greater than manual detection (p = .043), and in concordance with the histological findings, indicating higher sensitivity for early detection using the bioluminescence method. The measurements from the last timepoint of tumor growth assessment period showed higher bioluminescence signals from tumors with CAF15_23 than those with CAF15_13; this difference was not detected by the manual measurements. Histological evaluation confirmed statistically bigger tumors formed by DOKLuc co‐injected with the CAF15_23, a difference that was not indicated by the manual measurements. This brings further indications for the greater sensitivity of the bioluminescence method compared to the manual method that might carry subjective evaluations (eg, inflammation, tongue pull, position of the mouse, and lesion margins). Degradable copolymer scaffolds were used to further optimize and validate the model for use in screening tests for tumorigenesis of various microenvironmental cues from biomaterials. The manual monitoring of tumors at early stages was impossible because the tumors initially developed within the scaffold. However, this was not an impediment for bioluminescence. The correlation between bioluminescence signals and the golden standard method of histological examination was higher, confirming the method is more sensitive than manual measurements. Therefore, bioluminescence was further used solely to monitor the scaffolds when developing the model. A challenge for using the bioluminescence method would be monitoring of bigger tumors. We monitored a drop in intensity for a tumor developed from very high seeding density of DOKLuc + CAFs xenografts (1 × 106). We interpreted that to be an underestimation of the real bioluminescence signal from the cells because that tumor was later found to be cystic. Cystic content or necrosis that can occur in large or late stage tumors might reduce the production of light because of decreased proliferation or hypoxia.27, 39 Therefore, we recommend inoculating fewer cells per area of scaffold in order to circumvent these limitations and monitor tumor formation for longer period of times, as required in carcinogenesis studies. Although the use of such immunodeficient models greatly aids the development of “humanized” models of cancer using biomaterials,25 it does come with the caveat of no innate host immunity. Whereas this limitation prevents the current study of role of the immune system in tumor prevention in such models or the use of immunotherapeutic interventions, steps have been made to circumvent such constraints. Recent efforts have demonstrated that introduction of distinct human immune components are possible in mice xenografted with cancer cell lines,40 suggesting that further evolution of the NSG mice system may yet render models to study human immune reactions in cancer. Our model provides an abridged alternative to the years spent in rodent models to get tumors from biomaterials implanted solely in animals and foreign body tumorigenesis has several stages, with specific sequences of preneoplastic characteristics.12, 41 The processing time is reduced because of the ability of screening several animals simultaneously, which makes it cheaper compared to other high throughput imaging methods used in the field, such as MRI.

CONCLUSIONS

The model generated and validated in this study is a sensitive and reliable model for monitoring microenvironmentally induced carcinogenesis providing early, consistent surveillance of tumor development associated with implantation of scaffolds for tissue engineering.
  37 in total

Review 1.  Advances in imaging probes and optical microendoscopic imaging techniques for early in vivo cancer assessment.

Authors:  Numfon Khemthongcharoen; Romuald Jolivot; Santi Rattanavarin; Wibool Piyawattanametha
Journal:  Adv Drug Deliv Rev       Date:  2013-10-09       Impact factor: 15.470

Review 2.  Global epidemiology of oral and oropharyngeal cancer.

Authors:  Saman Warnakulasuriya
Journal:  Oral Oncol       Date:  2008-09-18       Impact factor: 5.337

3.  Generation of subcutaneous and intrahepatic human hepatocellular carcinoma xenografts in immunodeficient mice.

Authors:  Sharif U Ahmed; Murtuza Zair; Kui Chen; Matthew Iu; Feng He; Oyedele Adeyi; Sean P Cleary; Anand Ghanekar
Journal:  J Vis Exp       Date:  2013-09-25       Impact factor: 1.355

4.  Implantable microenvironments to attract hematopoietic stem/cancer cells.

Authors:  Jungwoo Lee; Matthew Li; Jack Milwid; Joshua Dunham; Claudio Vinegoni; Rostic Gorbatov; Yoshiko Iwamoto; Fangjing Wang; Keyue Shen; Kimberley Hatfield; Marianne Enger; Sahba Shafiee; Emmet McCormack; Benjamin L Ebert; Ralph Weissleder; Martin L Yarmush; Biju Parekkadan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-12       Impact factor: 11.205

5.  Biomaterial-induced sarcoma: A novel model to study preneoplastic change.

Authors:  C J Kirkpatrick; A Alves; H Köhler; J Kriegsmann; F Bittinger; M Otto; D F Williams; R Eloy
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

6.  In vivo bioluminescence imaging validation of a human biopsy-derived orthotopic mouse model of glioblastoma multiforme.

Authors:  Monika A Jarzabek; Peter C Huszthy; Kai O Skaftnesmo; Emmet McCormack; Patrick Dicker; Jochen H M Prehn; Rolf Bjerkvig; Annette T Byrne
Journal:  Mol Imaging       Date:  2013-05       Impact factor: 4.488

7.  Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma.

Authors:  Daniela Elena Costea; Allison Hills; Amani H Osman; Johanna Thurlow; Gabriela Kalna; Xiaohong Huang; Claudia Pena Murillo; Himalaya Parajuli; Salwa Suliman; Keerthi K Kulasekara; Anne Chr Johannessen; Max Partridge
Journal:  Cancer Res       Date:  2013-04-18       Impact factor: 12.701

8.  Sonoporation-enhanced chemotherapy significantly reduces primary tumour burden in an orthotopic pancreatic cancer xenograft.

Authors:  Spiros Kotopoulis; Anthony Delalande; Mihaela Popa; Veronika Mamaeva; Georg Dimcevski; Odd Helge Gilja; Michiel Postema; Bjørn Tore Gjertsen; Emmet McCormack
Journal:  Mol Imaging Biol       Date:  2014-02       Impact factor: 3.488

9.  Tumorigenicity of poly-L-lactide (PLLA) plates compared with medical-grade polyethylene.

Authors:  T Nakamura; Y Shimizu; N Okumura; T Matsui; S H Hyon; T Shimamoto
Journal:  J Biomed Mater Res       Date:  1994-01

Review 10.  Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery.

Authors:  Bruce A Ruggeri; Faye Camp; Sheila Miknyoczki
Journal:  Biochem Pharmacol       Date:  2013-06-28       Impact factor: 5.858

View more
  1 in total

1.  Integrin α11 is overexpressed by tumour stroma of head and neck squamous cell carcinoma and correlates positively with alpha smooth muscle actin expression.

Authors:  Himalaya Parajuli; Muy-Teck Teh; Siren Abrahamsen; Ingrid Christoffersen; Evelyn Neppelberg; Stein Lybak; Tarig Osman; Anne Chr Johannessen; Donald Gullberg; Kathrine Skarstein; Daniela Elena Costea
Journal:  J Oral Pathol Med       Date:  2016-10-04       Impact factor: 4.253

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.